
Abbvie Inc
NYSE:ABBV

Intrinsic Value
The intrinsic value of one
ABBV
stock under the Base Case scenario is
158
USD.
Compared to the current market price of 205.19 USD,
Abbvie Inc
is
Overvalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Abbvie Inc
Fundamental Analysis

With Humira’s patent protection expiring in key markets, AbbVie faces an impending revenue cliff that may be difficult to replace with newer therapies in the short term, potentially straining cash flows and earnings.
Skyrizi and Rinvoq have shown strong clinical data and commercial traction, signifying AbbVie’s potential to sustain leadership in immunology and mitigate the Humira patent cliff through these next-generation therapies.

Revenue & Expenses Breakdown
Abbvie Inc
Balance Sheet Decomposition
Abbvie Inc
Current Assets | 25.6B |
Cash & Short-Term Investments | 5.6B |
Receivables | 10.9B |
Other Current Assets | 9.1B |
Non-Current Assets | 109.6B |
Long-Term Investments | 279m |
PP&E | 5.1B |
Intangibles | 95B |
Other Non-Current Assets | 9.1B |
Free Cash Flow Analysis
Abbvie Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Abbvie Inc
Revenue
|
56.3B
USD
|
Cost of Revenue
|
-16.9B
USD
|
Gross Profit
|
39.4B
USD
|
Operating Expenses
|
-22.9B
USD
|
Operating Income
|
16.5B
USD
|
Other Expenses
|
-12.3B
USD
|
Net Income
|
4.2B
USD
|
ABBV Profitability Score
Profitability Due Diligence
Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Score
Abbvie Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
ABBV Solvency Score
Solvency Due Diligence
Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Score
Abbvie Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for
ABBV
is 219.74 USD
with a low forecast of 174.73 USD and a high forecast of 263.55 USD.
Dividends
Current shareholder yield for ABBV is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ABBV
stock under the Base Case scenario is
158
USD.
Compared to the current market price of 205.19 USD,
Abbvie Inc
is
Overvalued by 23%.